Literature DB >> 20386954

Evaluation of lung inflammation induced by intratracheal administration of LPS in mice: comparison between MRI and histology.

Giamaica Conti1, Stefano Tambalo, Gino Villetti, Silvia Catinella, Chiara Carnini, Franco Bassani, Nicolò Sonato, Andrea Sbarbati, Pasquina Marzola.   

Abstract

PURPOSE: To study the in vivo effect of intratracheal administration of lipopolysaccharide (LPS) in mice by magnetic resonance imaging (MRI) and to investigate the correlation with ex vivo histological evaluation of lung inflammation and oedema.
MATERIALS AND METHODS: LPS (or phosphate buffered saline) was administered intratracheally to thirty male Balb/C mice at a concentration of 0.3 mg/ml in a total volume of 100 microl. Animals were divided into fifteen LPS-treated and fifteen control mice. MR images were acquired 24 h after challenge in freely breathing animals with standard ECG-gated Gradient-Echo (GRE) sequences and, in a limited number of animals, with ECG-gated Ultrashort-echo time (UTE) sequences. After MRI, animals were sacrificed, and lungs were fixed and processed for histological analysis of the total volume of healthy lung tissue.
RESULTS: GRE images revealed the presence of high intensity signal in lungs of LPS-treated mice that was attributable to oedema caused by alveolar inflammation. In histological slices, regions of alterations in the normal alveolar microstructure were observed that could account for MRI findings. A good correlation was observed between the volumes of lesioned tissue measured by MRI and by histology. The volume of the lesion detected by GRE sequences was lower than the volume detected by UTE sequences.
CONCLUSIONS: The effect of intratracheal administration of LPS in mice was investigated by MRI and histology. A good correlation was observed between GRE-MRI and histological findings. MR images obtained with UTE sequences appear to be more sensitive to the presence of lesions than those obtained by standard GRE acquisitions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386954     DOI: 10.1007/s10334-010-0203-1

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  23 in total

Review 1.  Animal models for COPD.

Authors:  S D Shapiro
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

Review 2.  Techniques: magnetic resonance imaging of the lung provides potential for non-invasive preclinical evaluation of drugs.

Authors:  Nicolau Beckmann; Bruno Tigani; Lazzaro Mazzoni; John R Fozard
Journal:  Trends Pharmacol Sci       Date:  2003-10       Impact factor: 14.819

Review 3.  Global burden of COPD: risk factors, prevalence, and future trends.

Authors:  David M Mannino; A Sonia Buist
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

Review 4.  The technology of MRI--the next 10 years?

Authors:  A M Blamire
Journal:  Br J Radiol       Date:  2008-08       Impact factor: 3.039

5.  MRI of lung parenchyma in rats and mice using a gradient-echo sequence.

Authors:  N Beckmann; B Tigani; L Mazzoni; J R Fozard
Journal:  NMR Biomed       Date:  2001-08       Impact factor: 4.044

6.  (1)H MRI of pneumococcal pneumonia in a murine model.

Authors:  Pasquina Marzola; Anna Lanzoni; Elena Nicolato; Vincenza Di Modugno; Patrizia Cristofori; Francesco Osculati; Andrea Sbarbati
Journal:  J Magn Reson Imaging       Date:  2005-07       Impact factor: 4.813

7.  Proton MRI of lung parenchyma reflects allergen-induced airway remodeling and endotoxin-aroused hyporesponsiveness: a step toward ventilation studies in spontaneously breathing rats.

Authors:  Nicolau Beckmann; Catherine Cannet; Stefan Zurbruegg; Markus Rudin; Bruno Tigani
Journal:  Magn Reson Med       Date:  2004-08       Impact factor: 4.668

8.  Allergen-induced lung inflammation in actively sensitized mice assessed with MR imaging.

Authors:  François-Xavier Blé; Catherine Cannet; Stefan Zurbruegg; Harry Karmouty-Quintana; Reinhard Bergmann; Nelly Frossard; Alexandre Trifilieff; Nicolau Beckmann
Journal:  Radiology       Date:  2008-07-22       Impact factor: 11.105

9.  Subchronic endotoxin inhalation causes persistent airway disease.

Authors:  D M Brass; J D Savov; S H Gavett; N Haykal-Coates; D A Schwartz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-06-06       Impact factor: 5.464

10.  (1)H and hyperpolarized (3)He MR imaging of mouse with LPS-induced inflammation.

Authors:  Lars E Olsson; Amir Smailagic; Per-Ola Onnervik; Paul D Hockings
Journal:  J Magn Reson Imaging       Date:  2009-04       Impact factor: 4.813

View more
  11 in total

1.  IFN-τ Alleviates Lipopolysaccharide-Induced Inflammation by Suppressing NF-κB and MAPKs Pathway Activation in Mice.

Authors:  Haichong Wu; Gan Zhao; Kangfeng Jiang; Xiuying Chen; Guangze Rui; Changwei Qiu; Mengyao Guo; Ganzhen Deng
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

2.  Cyanidin-3-O-Glucoside Ameliorates Lipopolysaccharide-Induced Injury Both In Vivo and In Vitro Suppression of NF-κB and MAPK Pathways.

Authors:  Ming-Ming Ma; Yan Li; Xiang-Yong Liu; Wei-Wei Zhu; Xiang Ren; Gui-Qing Kong; Xiao Huang; Li-Peng Wang; Li-Qing Luo; Xiao-Zhi Wang
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 3.  An unmet clinical need: The history of thrombus imaging.

Authors:  Gregory M Lanza; Grace Cui; Anne H Schmieder; Huiying Zhang; John S Allen; Michael J Scott; Todd Williams; Xiaoxia Yang
Journal:  J Nucl Cardiol       Date:  2017-06-12       Impact factor: 5.952

4.  Primary Human Lung Alveolus-on-a-chip Model of Intravascular Thrombosis for Assessment of Therapeutics.

Authors:  A Jain; R Barrile; A D van der Meer; A Mammoto; T Mammoto; K De Ceunynck; O Aisiku; M A Otieno; C S Louden; G A Hamilton; R Flaumenhaft; D E Ingber
Journal:  Clin Pharmacol Ther       Date:  2017-07-14       Impact factor: 6.875

5.  Nobiletin-Ameliorated Lipopolysaccharide-Induced Inflammation in Acute Lung Injury by Suppression of NF-κB Pathway In Vivo and Vitro.

Authors:  Weifeng Li; Ruoqi Zhao; Xiumei Wang; Fang Liu; Jinmeng Zhao; Qing Yao; Wenbing Zhi; Zehong He; Xiaofeng Niu
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

6.  MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles.

Authors:  Achraf Al Faraj; Asma Sultana Shaik; Sibtain Afzal; Baraa Al Sayed; Rabih Halwani
Journal:  Int J Nanomedicine       Date:  2014-03-24

7.  Progranulin Improves Acute Lung Injury through Regulating the Differentiation of Regulatory T Cells and Interleukin-10 Immunomodulation to Promote Macrophage Polarization.

Authors:  Yan-Qing Chen; Chuan-Jiang Wang; Ke Xie; Ming Lei; Yu-Sen Chai; Fang Xu; Shi-Hui Lin
Journal:  Mediators Inflamm       Date:  2020-05-31       Impact factor: 4.711

8.  Development of Biodegradable Polycation-Based Inhalable Dry Gene Powders by Spray Freeze Drying.

Authors:  Tomoyuki Okuda; Yumiko Suzuki; Yuko Kobayashi; Takehiko Ishii; Satoshi Uchida; Keiji Itaka; Kazunori Kataoka; Hirokazu Okamoto
Journal:  Pharmaceutics       Date:  2015-08-26       Impact factor: 6.321

9.  Oridonin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-induced RAW264.7 cells and acute lung injury.

Authors:  Gan Zhao; Tao Zhang; Xiaofei Ma; Kangfeng Jiang; Haichong Wu; Changwei Qiu; Mengyao Guo; Ganzhen Deng
Journal:  Oncotarget       Date:  2017-07-12

10.  Interventional low-dose azithromycin attenuates cigarette smoke-induced emphysema and lung inflammation in mice.

Authors:  Matthew G Macowan; Hong Liu; Marianne D Keller; Miranda Ween; Rhys Hamon; Hai B Tran; Sandra Hodge
Journal:  Physiol Rep       Date:  2020-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.